Cargando…
Evaluation of adverse drug reaction in patients warfarin therapy
This research aimed to understand the adverse drug reaction (ADR) in heart disease outpatients who were administered warfarin at a hospital in Bandung city. The research was conducted using a cross-sectional design with an observational approach. Subsequently, data were collected from 74 patients wh...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9784044/ https://www.ncbi.nlm.nih.gov/pubmed/36568047 http://dx.doi.org/10.4103/japtr.japtr_439_22 |
_version_ | 1784857717235515392 |
---|---|
author | Putriana, Norisca Aliza Rusdiana, Taofik Rostinawati, Tina Akbar, Mohammad Rizki Destiani, Dika Pramita |
author_facet | Putriana, Norisca Aliza Rusdiana, Taofik Rostinawati, Tina Akbar, Mohammad Rizki Destiani, Dika Pramita |
author_sort | Putriana, Norisca Aliza |
collection | PubMed |
description | This research aimed to understand the adverse drug reaction (ADR) in heart disease outpatients who were administered warfarin at a hospital in Bandung city. The research was conducted using a cross-sectional design with an observational approach. Subsequently, data were collected from 74 patients who met the inclusion criteria. The causality assessment was made by the Naranjo Algorithm and the incidence of bleeding was classified based on the Bleedscore™. The result showed that the most common ADR were nausea, dizziness, stomach ache, ecchymosis, petechiae, bleeding in the mouth, melena, etc. Furthermore, the INR value was the most significant factor in the incidence of ADR. It was 6.445 using a value of P = 0.001 or a confidence interval of 95%. The most common side effect of warfarin in cardiac outpatients was superficial bleeding, followed by internal bleeding (melena). The INR value is the most significant factor in measuring the incidence of ADR. |
format | Online Article Text |
id | pubmed-9784044 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Wolters Kluwer - Medknow |
record_format | MEDLINE/PubMed |
spelling | pubmed-97840442022-12-24 Evaluation of adverse drug reaction in patients warfarin therapy Putriana, Norisca Aliza Rusdiana, Taofik Rostinawati, Tina Akbar, Mohammad Rizki Destiani, Dika Pramita J Adv Pharm Technol Res Original Article This research aimed to understand the adverse drug reaction (ADR) in heart disease outpatients who were administered warfarin at a hospital in Bandung city. The research was conducted using a cross-sectional design with an observational approach. Subsequently, data were collected from 74 patients who met the inclusion criteria. The causality assessment was made by the Naranjo Algorithm and the incidence of bleeding was classified based on the Bleedscore™. The result showed that the most common ADR were nausea, dizziness, stomach ache, ecchymosis, petechiae, bleeding in the mouth, melena, etc. Furthermore, the INR value was the most significant factor in the incidence of ADR. It was 6.445 using a value of P = 0.001 or a confidence interval of 95%. The most common side effect of warfarin in cardiac outpatients was superficial bleeding, followed by internal bleeding (melena). The INR value is the most significant factor in measuring the incidence of ADR. Wolters Kluwer - Medknow 2022 2022-10-10 /pmc/articles/PMC9784044/ /pubmed/36568047 http://dx.doi.org/10.4103/japtr.japtr_439_22 Text en Copyright: © 2022 Journal of Advanced Pharmaceutical Technology & Research https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
spellingShingle | Original Article Putriana, Norisca Aliza Rusdiana, Taofik Rostinawati, Tina Akbar, Mohammad Rizki Destiani, Dika Pramita Evaluation of adverse drug reaction in patients warfarin therapy |
title | Evaluation of adverse drug reaction in patients warfarin therapy |
title_full | Evaluation of adverse drug reaction in patients warfarin therapy |
title_fullStr | Evaluation of adverse drug reaction in patients warfarin therapy |
title_full_unstemmed | Evaluation of adverse drug reaction in patients warfarin therapy |
title_short | Evaluation of adverse drug reaction in patients warfarin therapy |
title_sort | evaluation of adverse drug reaction in patients warfarin therapy |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9784044/ https://www.ncbi.nlm.nih.gov/pubmed/36568047 http://dx.doi.org/10.4103/japtr.japtr_439_22 |
work_keys_str_mv | AT putriananoriscaaliza evaluationofadversedrugreactioninpatientswarfarintherapy AT rusdianataofik evaluationofadversedrugreactioninpatientswarfarintherapy AT rostinawatitina evaluationofadversedrugreactioninpatientswarfarintherapy AT akbarmohammadrizki evaluationofadversedrugreactioninpatientswarfarintherapy AT destianidikapramita evaluationofadversedrugreactioninpatientswarfarintherapy |